Tuesday, August 16, 2011

Clinical Investigators to Present Data on Nymox BPH Drug at American Urological Association Meeting October 19

Listen to this Post. Powered by iSpeech.org



HASBROUCK HEIGHTS, N.J., Aug. 16, 2011 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (Nasdaq:NYMX) today announced that new clinical trial data concerning the safety and efficacy of the Company’s NX-1207 for benign prostatic hyperplasia (BPH) will be presented at the North Central Section of the American Urological Association Meeting in Rancho Mirage, CA October 19, 2011. The paper is authored by leading independent clinical research investigators participating in the U.S. clinical trials of NX-1207.



NX-1207 is a novel patented drug developed by Nymox which is currently in Phase 3 trials. The drug has successfully completed a series of blinded controlled multi-center U.S. clinical trials where a single dose of NX-1207 has been found to produce symptomatic improvements about double that reported for currently approved BPH drugs without causing the sexual or cardiovascular side effects associated with those drugs. Follow-up studies have shown evidence of long lasting benefit with a significant proportion of men who received a single dose reporting maintained improvement in BPH symptoms without other treatments for up to 7� years. NX-1207 is injected by a urologist in an office setting and involves little or no pain or discomfort. For more information about the NX-1207 Phase 3 clinical trials please go to www.clinicaltrials.gov or contact Nymox at info@nymox.com.



BPH treatment represents a growing market with more than 100 million men worldwide being estimated to suffer from BPH symptoms. The disorder is a common affliction of older men, affecting approximately half of men over age 50 and close to 90% of men by age 80, and is associated with growth in prostate size as men age. BPH causes difficulties with urination associated with aging, such as nocturia, urge to void frequently, hesitancy, weak stream, and other problems.



This press release contains certain “forward-looking statements” as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. Such factors are detailed from time to time in Nymox’s filings with the United States Securities and Exchange Commission and other regulatory authorities.


CONTACT: Roy Wolvin
Nymox Pharmaceutical Corporation
1-800-93NYMOX
www.nymox.com



News

http://bit.ly/pkE7Jk

Supportcomm Selects Motricity to Expand Its Mobile Capabilities for More Than 200 Million Subscribers in Latin America

Listen to this Post. Powered by iSpeech.org



SAO PAULO and BELLEVUE, Wash., Aug. 16, 2011 (GLOBE NEWSWIRE) — Supportcomm, the first company in Brazil to provide mobile marketing and one of the largest providers of managed data services in the region, has chosen Motricity (Nasdaq:MOTR) to expand its mobile services platform in Latin America. Implementing Motricity’s technology to support its content management and product solutions, Supportcomm will expand its service offerings to the largest mobile operators in the region � Claro, Vivo, TIM and Oi.



“We’ve chosen to work with Motricity based on its proven expertise and success in the mobile industry with the world’s largest mobile operators. As we continue to expand our presence in Latin America, we needed a partner and technology that could help drive our business forward,” said Cesar Frantz, chief executive officer of Supportcomm. “We feel Motricity will enable a more dynamic mobile data experience for the rapidly growing number of mobile users in Brazil.”



Latin America is experiencing unprecedented growth in the mobile telecommunications sector. According to a recently study published by ABI Research, the average global growth rate for mobile data services from Q1 2010 to Q1 2011 was 20.3 percent, while Latin America saw a 40.3 percent increase during the same period. In addition, a 153 percent increase in smartphone shipments to Latin America in 2010 is further evidence of the tremendous growth in this region.



“Brazil is one the largest markets in the world, so we’re excited to be chosen by Supportcomm to expand their mobile services offering and enter a region that is seeing tremendous growth and opportunity in mobile,” said Ryan Wuerch, chief executive officer of Motricity. “Motricity’s proprietary technology will enable Supportcomm to offer an unmatched opportunity to drive reach and engagement among end users.”



As part of the deal, Supportcomm will implement Motricity’s mCore platform which includes feature rich digital content management that will enable a premium and compelling interactive experience for end users. On top of the platform layer will be the tools to develop, manage and deploy mobile marketing and advertising campaigns. In addition, Supportcomm will have access to the metrics and analytics needed to provide a personalized and highly targeted experience for their customers.��



About Motricity



Motricity (Nasdaq:MOTR) empowers mobile operators, brands and advertising agencies to maximize the reach and economic potential of the mobile ecosystem through the delivery of relevance-driven merchandising, marketing and advertising solutions. Motricity leverages advanced predictive analytics capabilities to deliver the right stuff, to the right person at the right time. Motricity provides their entire suite of mobile data service solutions through one, integrated, highly scalable managed service platform. Motricity’s unique combination of technology, expertise and go-to-market approach deliver definitive return-on-investment for our mobile operator, brand and advertising agency customers. For more information, visit www.motricity.com or follow the company on Twitter@motricity.



The Motricity, Inc. logo is available at http://ping.fm/SiMid



About Supportcomm



Supportcomm is an experienced Value Added Services (VAS) company and one of the most qualified players in the Brazilian market.�Serving�both B2B and B2C customers, Supportcomm (Scomm) powers state-of-the-art solutions such as m-payment, subscription-based mobile downloads, SMS infotainment and Interactive Voice Response (IVR). Scomm serves customers such as�Claro Idéias, America Móvil / Claro white-label WAP virtual store; and�Portal de Voz, Telefónica / Vivo white-label voice entertainment and IVR service, two valuable partnerships that span over a decade. Providing a full range of services and products, Scomm offers mobile downloads and SMS content management for mobile and web virtual stores, online products and media reports,�strategic competitive intelligence, override featured platforms, on-demand projects team�and much more. Scomm provides value-added service for mobile services and digital goods. For more information visit www.supportcomm.com.br or email�negocios@supportcomm.com.br


CONTACT: Media Contact:
Motricity
Karl Stetson, Edelman for Motricity
206-268-2215
Karl.Stetson@edelman.com



News

http://bit.ly/nAHm8x

Applied Geo Technologies, Inc. Achieves AS9100C Quality Registration

Listen to this Post. Powered by iSpeech.org



CHOCTAW, Miss. and HUNTSVILLE, Ala., Aug. 16, 2011 (GLOBE NEWSWIRE) — Applied Geo Technologies, Inc. (AGT) has achieved AS9100C registration, which also incorporates the requirements of ISO 9001:2008, for its Choctaw, Miss. location, validating its quality management system meets and exceeds the needs of the aviation, space and defense markets. This achievement is the latest step in AGT’s continuing quality processes and goals designed to provide mission-critical products and services to its government and commercial customers.



As a provider of cabling and wiring harness engineering design and manufacturing services for more than 20 years, AS9100C registration allows AGT to expand its expertise from ground vehicles into the aerospace market, where it currently provides wiring for the Patriot missile system and small commercial aircraft.



“This achievement is a testimony to our employees’ commitment for continual improvement,” said David Ogg, AGT President and CEO. “Our current government and commercial customers recognize us as a quality provider of high-quality products and services, and our goal is for AGT to always be who they think of first when supplies or manufacturing services are needed.”



AS9100C, developed by the International Organization for Standardization, is an internationally recognized quality standard specific to the aviation, space and defense sectors, and equips manufacturers to employ quality management system practices in customer service; product development and design; testing and production methodologies; process control; traceability; and risk mitigation, among others. Alamo Learning Systems consulted with AGT for training and process development, and the audits were conducted by ABS Quality Evaluations.



About AGT



AGT is a premier provider of products and services to aerospace, defense and commercial companies. Services include logistics support, program management, laboratory management, field engineering, business services support, and manufacturing. Products include cable and wiring harnesses, MARCbot surveillance robot and flexible fabric fuel bladders. AGT is certified by the U.S. Small Business Administration (SBA) as a Tribally-owned 8(a), HUBZone, Small Disadvantaged Business and is wholly-owned by the Mississippi Band of Choctaw Indians. www.appliedgeotech.com



This information was brought to you by Cision http://www.cisionwire.com
http://www.cisionwire.com/applied-geo-technologies/r/applied-geo-technologies–inc–achieves-as9100c-quality-registration,c9150736


CONTACT:  EDITORS:
For more information contact:
C.C. Fridlin
AGT Business Development Director
256-890-9139
ccfridlin@appliedgeotech.com

Applied Geo Technologies, Inc.
375 Industrial Road
Choctaw, MS 39350
Tel: (601) 389-3084
Fax: (601) 389-3015
appliedgeotech.com



News

http://bit.ly/rjkkCQ

Affirmative Insurance Holdings Reports Second Quarter 2011 Financial Results

Listen to this Post. Powered by iSpeech.org



ADDISON, Texas, Aug. 15, 2011 (GLOBE NEWSWIRE) — Affirmative Insurance Holdings, Inc. (Nasdaq:AFFM), a leading distributor and producer of non-standard personal automobile insurance policies, reported consolidated financial results for the three and six months ended June 30, 2011.



Gary Kusumi, Chief Executive Officer, stated, “Our second quarter results demonstrate continued progress as a result of actions taken with respect to pricing, underwriting, expense reduction and claims.�Although we have not yet achieved overall profitability, two consecutive quarters of positive trends are encouraging.�We introduced our new multi-variate (segmented) product in three of our largest states, Louisiana, Texas and Alabama, in the second quarter and expect to roll-out the product in Illinois, another major state for us, by year’s end. Although these trends are positive and establish a foundation for success in the future, we remain concerned about premium levels. Our plan anticipated a significant reduction in premium volume as we increased rates; however, continuing difficult macro-economic conditions may affect our customers’ financial ability to purchase insurance from us.�To address this concern, we continue to closely monitor our prices to ensure we are competitive in the marketplace while maintaining our profit margin objective.�We also are focused on actively marketing our segmented product aggressively to new customers.�While the macro-economic environment likely will present short-term challenges, I remain confident that the actions we have taken and the changes we are making will lead to continued improved financial performance.”



Operating Performance




  • Gross premiums written for the second quarter of 2011 decreased .4 million, or 32.0%,�compared with the second quarter of 2010.�For the first half of 2011, gross premiums written decreased .7 million, or 33.0%, compared with 2010.�These decreases were due to a number of actions taken during 2010 and into 2011 to increase prices and strengthen underwriting standards.




  • Total revenues for the second quarter of 2011 decreased .7 million, a 45.5% decrease from the second quarter of 2010.� Total revenues for the first half of 2011 decreased 2.0 million, a 42.5% decrease from 2010. These decreases were due to the decreases in gross premiums written as well as the impact of the quota-share reinsurance treaties on the 2011 business.




  • Losses and loss adjustment expenses were 63.0% of net earned premium (the loss ratio), compared with a loss ratio of 83.9% in the comparable prior year quarter.� For the first half of 2011, loss and loss adjustment expenses decreased to a loss ratio of 71.8% compared with 80.3% in 2010. �The accident year decline in the loss ratio for the quarter was due to pricing and underwriting actions taken as well as claims handling initiatives.�The quota-share reinsurance agreements entered into in the fourth quarter of 2010 and 2011 impacted the loss ratio by 4 percentage points for the first six months of 2011 in comparison to the same period in 2010.� This is due to all of the ceding commission income being booked in selling, general and administrative expenses.� Therefore, the loss adjustment expenses include both our portion as well as the reinsurer’s portion.� Excluding this impact, the accident period loss ratio decreased by 2.6 percentage points due to the initiatives stated above for the period.




  • Selling, general and administrative (SG&A) expenses decreased .3 million in the second quarter of 2011, or 33.5%, to .3 million, compared with .5 million in the second quarter of 2010. �For the first half of 2011, SG&A expenses decreased .1 million, or 27.2%, compared with the prior year period. The decreases were primarily due to the decline in premium production and ceding commissions from the quota-share reinsurance agreements.�



About Affirmative



Affirmative Insurance Holdings, Inc. is a distributor and producer of non-standard personal automobile insurance policies and related products and services for individual consumers in targeted geographic markets. Non-standard personal automobile insurance policies provide coverage to drivers who find it difficult to obtain insurance from standard automobile insurance companies due to their lack of prior insurance, age, driving record, limited financial resources or other factors. Non-standard personal automobile insurance policies generally require higher premiums than standard automobile insurance policies.



The Affirmative Insurance Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3443



This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by, among other things, the use of forward-looking terms such as “likely,” “typically,” “may,” “intends,” “expects,” “believes,” “anticipates,” “estimates,” “projects,” “targets,” “forecasts,” “seeks,” “potential,” , or “attempts” or the negative of such terms or other variations on such terms or comparable terminology. By their nature, these statements are subject to risks, uncertainties and other factors, which could cause actual future results to differ materially from those results expressed or implied by such forward-looking statements.



Do not unduly rely on forward-looking statements. They give the Company’s expectations about the future and are not guarantees. Forward-looking statements speak only as of the date they are made, and, except as required by law, the Company does not intend to update them to reflect changes that occur after that date. For a discussion of factors that may cause actual results to differ from expectations, refer to the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2010. Any factor described in this press release or in any document referred to in this press release could, by itself or together with one or more other factors, adversely affect the Company’s business, earnings and/or financial condition.


CONTACT: Michael J. McClure
Executive Vice President and Chief Financial Officer
(630) 560-7205
Michael.mcclure@affirmativeinsurance.com



News

http://bit.ly/nBlPge

RXi Pharmaceuticals Provides Update and Reports Financial Results for Q2 2011

Listen to this Post. Powered by iSpeech.org





  • NeuVax™ (E75) makes significant progress towards initiating the Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax™ Treatment) study in 1H, 2012



WORCESTER, Mass., Aug. 15, 2011 (GLOBE NEWSWIRE) — RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, today reported its financial results for the quarter ended June 30, 2011.



RXi currently is focusing its effort primarily on its lead product, NeuVax (E75), a peptide-based immunotherapy. The company expects to initiate its Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax™ Treatment) study in the first half of 2012 under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA).



Recent Highlights



Since RXi’s acquisition of NeuVax in April 2011, the Company has aggressively completed several operational steps towards initiating the Phase 3 PRESENT trial including:




  • Dr. Beth Mittendorf announced as the Phase 3 Principle Investigator. Elizabeth A. Mittendorf, MD, Assistant Professor in the Department of Surgical Oncology at the University of Texas M. D. Anderson Cancer Center (MDACC).�At MDACC, Dr. Mittendorf focuses both her clinical and non-clinical (i.e., laboratory) efforts on the study of breast cancer with a specific interest in breast cancer immunotherapy.�Her laboratory work is focused on identifying novel tumor antigens and investigating aspects of the tumor microenvironment that impact the response to anti-cancer vaccination.�Dr. Mittendorf has published extensively on breast cancer immunotherapy as well as on subjects related to the clinical management of breast cancer patients,�


  • Phase 3 site IRB approvals obtained. Obtained conditional Institutional Review Board approval of the NeuVax protocol from two sites;�a total of at least five key sites are targeted for approval in Q4 2011,


  • Clinical Research Organization (CRO) selected to manage the international, multicenter Phase 3 PRESENT trial, and


  • Product manufacturing filings completed.�Submitted manufacturing amendment to the U.S. Food and Drug Administration (FDA), as well as initiated preparation of final Phase 3 clinical trial drug product.



“In just over three months since the acquisition of NeuVax, we have made significant progress towards advancing into a pivotal Phase 3 trial to address a large patient population where there is currently a significant unmet medical need,” stated Mark J. Ahn, PhD, President and Chief Executive Officer of RXi Pharmaceuticals.�”In addition, during the first half of 2011, RXi raised over million of capital and has successfully completed a rapid transition from a research company to a late clinical stage development company.”



Clinical Data Presentations:




  • Presented positive 36-month data from the NeuVax Phase 2 trial at the American Society of Clinical Oncology (ASCO) annual meeting.�Patients in the Phase 3 target patient population maintained a strong response to NeuVax with a 0% recurrence in the treated group versus 22.2% in the untreated group, demonstrating statistical significance.�NeuVax continued to demonstrate an excellent safety profile with no serious adverse events.�


  • Presented Phase 2 data from the combination of NeuVax and Herceptin® in HER2 3+ patients at ASCO.�The HER2 3+ patients in the study who received NeuVax in combination with Herceptin indicated no relapses in the patient population, when compared to a relapse rate of about 13% for patients who received Herceptin only, which is consistent with historical norms for this patient population.�This data represents a potential improvement to the current standard of care for this patient population, and a possible expansion of the target patient population for NeuVax in the future.



Corporate:




  • Strengthened NeuVax patent portfolio.�Acquired two additional patents covering worldwide rights to develop and commercialize NeuVax (E75) in combination with trastuzumab (Herceptin®; Genentech/Roche); and use in low-to-intermediate HER2+ breast cancer patients not eligible for Herceptin therapy.


  • Awarded a total of 8,000 in National Institutes of Health (NIH) Grants to Advance RNAi Therapeutics.�Awarded two Small Business Innovation Research grants from the NIH focused on the preclinical development of novel RNAi therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders, as well as funding for a project seeking to improve the delivery of RNAi therapeutics through medicinal chemistry.


  • RXi Pharmaceuticals and the University of Massachusetts Medical School (UMMS) Announce Massachusetts Life Sciences Center Cooperative (MLSC) Research Grant for RNAi Therapeutics for ALS.�The grant will contribute towards funding an ongoing collaboration between UMMS and RXi to develop a new treatment for ALS using RXI’s proprietary self-delivering RNAi therapeutic platform (sd-rxRNA™).�The MLSC grant amount is 0,000 per year for two years, and subject to a formalized agreement between the parties, matched dollar for dollar by RXi, totaling to up to 0,000 in funding for this project.


  • Completed million public offering to accelerate the Phase 3 PRESENT trial.



Quarterly Financial Highlights:



Cash, Cash Equivalents and Short-Term Investments



As of June 30, 2011, cash, cash equivalents and short-term investments totaled .9 million, compared with cash and cash equivalents of .9 million at December 31, 2010. This .0 million increase is attributable to the closing of two underwritten public offerings that provided net cash proceeds of approximately .2 million after underwriting fees and other estimated offering expenses (the March 2011 offering of net proceeds of .3 million and the April 2011 offering of net proceeds of .9 million), offset by net cash used in operating activities of .2 million for the six months ended June 30, 2011.



Net Loss



Net loss for the three months ended June 30, 2011 was .4 million or .04 per basic and diluted share, compared with a net loss of .1 million, or .12 per basic and diluted share, for the comparable period in 2010. RXi also reported a net loss of .2 million, or .18 per basic and diluted share, for the six months ended June 30, 2011, compared with a net loss of .0 million, or .35 per basic and diluted share, for the six months ended June 30, 2010. The decrease in net loss for the three and six months ended June 30, 2011 compared to the same periods in the prior year was primarily attributable to the non-cash expense as a result of the change in fair value of warrant liability of .2 million and .7 million, respectively, which was primarily due to changes in our Black-Scholes assumptions.



Net loss from operations decreased to .6 million in the second quarter of 2011 from .8 million in the second quarter of 2010, and increased to .9 million for the six months ended June 30, 2011 compared to .2 million for the comparable period in 2010. This decrease of .2 million, or 4%, in net loss from operations for the quarter ended June 30, 2011 compared to the quarter ended June 30, 2010 was primarily due to a .2 million decrease in non-cash equity compensation offset by an increase of .0 million in research and development expenses, as noted below.�The increase of .7 million, or 8%, in net loss from operations for the six months ended June 30, 2011 compared to six months ended June 30, 2010 was primarily the result of a decrease of .2 million in non-cash equity compensation offset by a .5 million increase in research and development expenses and an increase of .4 million in general and administrative expenses, as noted below.



Research and Development Expense



Research and development expenses increased to .7 million in the second quarter of 2011 from .3 million in the second quarter of 2010, and increased to .8 million for the first six months of 2011 from .2 million for the first six months of 2010. The increase in research and development expenses for the second quarter of 2011 compared with the second quarter of 2010 of .4 million, or 17%, was primarily due to an increase of .0 million in research and development cash expenses due to a ramp up in NeuVax-related consulting fees and activities in our progression toward releasing NeuVax off clinical hold offset by a decrease of .7 million in non-employee non-cash stock based compensation related to a change in our Black-Scholes assumptions and .1 million in employee non-cash stock based compensation. The increase of .6 million, or 15% for the six months ended June 30, 2011 compared to the six months ended June 30, 2010 was primarily due to an increase of .5 million in research and development cash expenses primarily related to the ramp-up in NeuVax-related development activities, which was partially offset by a decrease of .8 million in non-employee non-cash stock based compensation and a .1 million decrease in employee non-cash stock based compensation.



General and Administrative Expenses



General and administrative expenses decreased to .9 million in the second quarter of 2011 from .5 million in the second quarter of 2010, and increased to .1 million for the first six months of 2011 from .0 million for the first six months in 2010. The decrease in general and administrative expenses for the second quarter of 2011 compared with the second quarter of 2010 of .6 million, or 24%, was primarily due to a .3 million decrease in non-cash employee stock based compensation and a .2 million decrease in non-cash stock based compensation expense related to a change in our Black-Scholes assumptions. Excluding these non-cash items, general and administrative expenses decreased to .6 million for the quarter ended June 30, 2011 from .7 million for the�quarter ended June 30, 2010. The decrease of .1 million was primarily due to a decrease in headcount offset by severance payments in connection with a reduction in force. The decrease of .1 million, or 2%, for the six months ended June 30, 2011 compared to the six months ended June 30, 2010 was primarily due to a .4 million decrease in non-cash stock based compensation related to a warrant issued for business advisory services offset by a .1 million increase in non-cash stock based compensation.�Excluding these non-cash items, general and administrative expenses increased to .5 million for the six months ended June 30, 2011 from .1 million for the six months ended June 30, 2010. This increase of .4 million was primarily due to severance payments in connection with a reduction in force.



About NeuVax™ (E75)



NeuVax consists of the Her2/neu (E75) peptide derived from HER2 combined with the immune adjuvant granulocyte macrophage-colony stimulating factor.�Treatment with NeuVax stimulates cytotoxic (CD8+) T cells in a highly specific manner to target cells expressing any level of HER2.�NeuVax is given as an intradermal injection once a month for six months, followed by a booster injection once every six months.�Based on a successful Phase 2 trial, which achieved its primary endpoint of disease-free survival, the FDA granted NeuVax a Special Protocol Assessment for its Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax™ Treatment) study.�This Phase 3 multicenter trial is expected to commence in the first half of 2012.



According to the National Cancer Institute, over 200,000 women in the U.S. are diagnosed with breast cancer annually.�Of these women, about 75% test positive for Human Epidermal growth factor Receptor 2 (IHC 1+, 2+ or 3+).�Only 25% of all breast cancer patients, those with HER2 3+ disease are eligible for Herceptin® (trastuzumab; Roche-Genentech) which had revenues of over billion in 2010.�NeuVax targets the remaining 50% of HER2 positive patients (HER2 1+ and 2+) who achieve remission with current standard of care, but have no available HER2 targeted adjuvant treatment options to maintain their disease free status.



About RXI-109



RXi has initiated development of clinical candidate RXI-109, a self-delivering RNAi compound (sd-rxRNA) for the reduction of dermal scarring in planned surgeries. RXI-109 is designed to reduce the expression of CTGF (connective tissue growth factor), a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin. RXi has manufactured RXI-109 with an experienced cGMP oligonucleotide manufacturer to support its IND enabling toxicology program and the planned clinical trial. Pending FDA review, the Company intends to use an innovative clinical trial design to study safety and tolerability as well as initial efficacy in its first clinical trial targeted for 2012.



About RXi Pharmaceuticals Corporation



RXi Pharmaceuticals Corporation (Nasdaq:RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies using targeted biotherapeutics thus addressing major unmet medical needs.�For more information, visit www.rxipharma.com.



The RXi Pharmaceuticals Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10128



Forward-Looking Statements



This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the future expectations, plans and prospects of the development of RXi Pharmaceuticals Corporation’s products. These forward-looking statements about future expectations, plans and prospects of the development of the Company’s products are subject to a number of risks, uncertainties and assumptions, including those identified under “Risk Factors” in the Company’s most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q and in other filings the Company periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements. The Company does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.


CONTACT: RXi Pharmaceuticals
Tamara McGrillen
508-929-3615
ir@rxipharma.com

or

Remy Bernarda
IR Sense, LLC
415-203-6386
remy@irsense.com



News

http://bit.ly/pukXqg

Monday, August 15, 2011

Polar Wireless Corp. Files Form 15 With the Securities and Exchange Commission

Listen to this Post. Powered by iSpeech.org



RICHMOND HILL, Ontario, Aug. 15, 2011 (GLOBE NEWSWIRE) — Polar Wireless Corp. (OTCBB:BCDI) announced today the filing of Form 15 with the U.S. Securities and Exchange Commission. On August 15, 2011, the company filed the Form 15 to provide notice of a suspension of the duty to file reports under Section 12(h) of the Securities Exchange Act of 1934. Upon filing Form 15, Polar Wireless’ obligation to file periodic and other reports with the SEC, including forms 10-K, 10-Q, and 8-K are immediately suspended.



Polar Wireless is taking this action based on the following considerations:




  • Overall demands placed on management to comply with SEC reporting obligations, taking valuable time from managing essential aspects of the business


  • Costs tied to the preparation, review, editing and submission of periodic and other reports required by the SEC



The company’s shares will still be available for trading on the Over-The-Counter Pink Sheets.



About Polar Wireless Corp:



Polar Wireless offers the first Worldwide SIM Card that combines with a subscribers home SIM to provide the lowest rates on Voice, SMS and data services when roaming. Polar Wireless aspires to build the largest proprietary Worldwide Mobile Virtual Network that automatically reroutes customers’ calls through inexpensive telecommunications channels when they are roaming.�The Polar SIMs transformative technology is the FIRST to allow a subscriber to keep their existing mobile phone and phone number while taking advantage of discounted roaming rates.


CONTACT: George Perlin
President and Chief Executive Officer
(905) 881-8444



News

http://bit.ly/ojY8ea

Informatica Wins 'Data Quality' Category In 2011 CRM Market Leaders' Awards

Listen to this Post. Powered by iSpeech.org



REDWOOD CITY, Calif., Aug. 15, 2011 (GLOBE NEWSWIRE) — Informatica Corporation (NASDAQ: INFA), the world's number one independent provider of data integration software, today announced it has been named the winner of the Data Quality category in CRM Magazine's 2011 CRM Market Leaders Awards.



Built on the Informatica Platform, the Informatica Data Quality solution empowers line-of-business managers, data stewards and business analysts to collaborate in addressing enterprise data quality. By making the business more self-sufficient and IT more productive, data quality improvement can become an enterprise wide focus, greatly reducing the dependence on scarce IT resources while driving better business outcomes. Leveraging the Informatica Data Quality solution, global enterprises are building better data quality solutions that help improve revenue, reduce cost and manage risk.�Fortune 500 companies around the globe unlock trusted data across the enterprise by:




  • Proactively monitoring and cleansing the data for all applications and keeping it clean.


  • Enabling the business to share in the responsibility for data quality and data governance.


  • Driving better business outcomes with trusted enterprise data.



According to CRM Magazine: “Informatica's data quality solution is often on the short list with our clients, even if they are not an Informatica shop,” Ray Wang, principal analyst and CEO of Constellation Research says. That's a pretty powerful statement that sums up Informatica's victory for the second consecutive year. In fact, in 2009, an analyst proclaimed that the company “will be hands-down [the one] to beat” in a year or two. Well, it's now been two years and it looks like Informatica doesn't plan to go anywhere soon. Scoring an impressive 4.3 for both company direction and depth of functionality and a 4.0 for customer satisfaction, Informatica was the clear winner in the data quality category this year. “I really like what Informatica is doing,” Michael Fauscette, group vice president of software business solutions at IDC says. “Their developments are very interesting tools, and in some areas they might be a little ahead.”



“Data quality is at the heart of the majority of MDM and Data Governance initiatives,” said Ivan Chong, general manager, Data Quality Business, Informatica. “Informatica continues to consistently execute on our promise to deliver the best data quality technology to the market and our customers continue to leverage their investment in Information Data Quality gaining a competitive advantage as they see the need for trustworthy and authoritative data across their enterprises.”



Informatica Data Quality was also recently recognized as a Leader in the Gartner 2011 Magic Quadrant for Data Quality Tools report.



Tweet this: �News: @InformaticaCorp DataQuality Wins @destinationCRM 2011 CRM Market Leaders Award http://bit.ly/r2vNRq MDM



About Informatica


Informatica Corporation (NASDAQ: INFA) is the world's number one independent provider of data integration software. Organizations around the world turn to Informatica to gain a competitive advantage in today's global information economy with timely, relevant and trustworthy data for their top business imperatives. Worldwide, over 4,440 enterprises rely on Informatica for data integration and data quality solutions to access, integrate and trust their information assets held in the traditional enterprise, off premise and in the Cloud. For more information, call +1 650-385-5000 (1-800-653-3871 in the U.S.), or visit�www.informatica.com. Connect with Informatica at http://ping.fm/foNiS,�http://ping.fm/INtqe and�http://ping.fm/Jjdmr.



###



Note: Informatica, Informatica Platform and Informatica Data Quality are registered trademarks of Informatica Corporation in the United States and in jurisdictions throughout the world. All other company and product names may be trade names or trademarks of their respective owners.


CONTACT: Deborah Wiltshire
Informatica Corporation
+1 650 385 5360
mobile/+1 650 862 8186
dwiltshire@informatica.com

Mike Merwin
Ogilvy PR
+1 415 677 2714
infaopr@ogilvypr.com



News

http://bit.ly/n1xTDG

Navatar Group and Celera Systems, LLC Announce Mutual Fund Sales Reporting With Transfer Agent and Broker Feeds on Salesforce

Listen to this Post. Powered by iSpeech.org



NEW YORK, Aug. 15, 2011 (GLOBE NEWSWIRE) — Navatar Group, a leading cloud service provider for financial services, today announced their Mutual Fund Cloud solution designed to help mutual fund wholesalers increase distribution of their asset management products such as mutual funds, exchange-traded funds (ETFs) and private investment funds, without investing in any software, hardware or expensive services. Navatar’s solution provides timely and accurate fund sales and performance information for all investment products and distribution channels.



Navatar’s Mutual Fund Cloud is already used by firms such as ALPS Fund Services, Jefferies & Co, and Guggenheim Partners. It seamlessly combines sophisticated sales reporting with transfer agent and broker feeds from Celera Systems. Navatar’s Mutual Fund Cloud is built on salesforce.com’s cloud platform and is available for a low monthly fee. A demo is available at:



http://ping.fm/OkLa1



Celera’s feeds include subaccount information for tracking transactions and assets under management, as well as for SEC Rule 22c-2 monitoring. It includes all major transfer agents and intermediaries – Charles Schwab, TD Ameritrade, Pershing and many others.



Celera Systems works with each client to create and maintain customized loader converters to accommodate proprietary feeds such as separately managed accounts or additional lines of business.



“Navatar’s goal is to help mutual fund wholesalers focus on increasing their assets under management, as opposed to maintaining software, hardware and data,” said Alok Misra, Principal, Navatar Group. “With Celera Systems, we have created a turnkey cloud solution for mutual fund companies.”



“Navatar Group is one of the leaders in providing cloud computing for financial firms,” noted Mike Guinta, Principal and Director of Product Development, Celera Systems. “We are very excited about the Mutual Fund Cloud we have created with Navatar and the attention it is generating.”



Live Demo



For a live, interactive demo of Navatar Mutual Fund Cloud, contact 212 461 2140 or sales@navatargroup.com.



About Navatar Group



Navatar Group (http://ping.fm/xvL8v) is a global cloud service provider and a top ISV partner of salesforce.com. Navatar Group provides Cloud Computing for Wall Street firms, with customers in more than 20 countries. We pioneered the concept of cloud products where customers don’t pay anything for implementation or support services. Navatar’s financial cloud solutions for Capital Markets, Asset Management & Banking are used by firms such as Jefferies & Co, Guggenheim Partners and MidOcean Partners. Navatar’s consulting arm advises and helps ISVs migrate to the cloud. We are headquartered on Wall Street, New York with offices in Washington DC and New Delhi, India.



The Navatar Group logo is available at http://ping.fm/KD3Q2



About Celera Systems, LLC



Celera Systems is dedicated to helping financial services institutions grow by offering World Class products designed to help maintain stability, improve market share and enhance business performance. Celera’s solid, mature, proven products integrate seamlessly with end-user brand identities and are adaptable to the changing demands of the marketplace. Celera is headquartered in Mequon, WI, with offices in Novato, CA and Charlotte, NC.�


CONTACT: Allan Siegert
asiegert@navatargroup.com
212 461 2140



News

http://bit.ly/qfUUod

Aplifi Launches Six New Life Insurance Carriers on AFFIRM for Life

Listen to this Post. Powered by iSpeech.org



POMPANO BEACH, Fla., Aug. 15, 2011 (GLOBE NEWSWIRE) — Aplifi (formerly Blue Frog Solutions), a leading provider of Life & Annuity Order Management, Client Management and Marketing solutions for the insurance and financial sectors, announces that it has just launched six new life insurance carriers on its AFFIRM for Life eApplication platform. These carriers are among the most heavily utilized life insurance organizations in the world.



With this recent release the industry finally has a solid choice for eApplications.�The AFFIRM for Life platform provides a robust foundation that, unlike other platforms on the market, delivers true flexibility at both the carrier and distributor level.�� Aplifi, typically, offers the AFFIRM for Life platform to brokerage agencies, broker dealers, and banks at no cost and can provide single sign on or automated producer registration out of the box.



The six carriers that are being released on the AFFIRM for Life platform have consistently been seen as technological leaders supporting the field with innovative solutions and creative products that help drive new sales while decreasing costs to its partners.



“We are ecstatic to have all six of these great partners come on AFFIRM at the same time. I have to give these carriers a lot of credit as it took less than four weeks to get their products ready for sale through platform and the first set of applications to start flowing,” said Dan Smith, President and CEO of Aplifi.�”We see giving the distribution channel and carriers a choice in platforms as a positive for the industry and a sign that electronic processes are here to stay.”



Affirm for Life is currently being�implemented in a number of broker dealer and bank locations and has had many brokerage general agencies signing up for the service over the past several months. In addition, the platform is expected to have another four to six carriers available by the end of this year.



For more information on Aplifi or AFFIRM for Life please call us at 800.861.8908 or visit us at www.aplifi.com.



About Aplifi:



Aplifi (www.aplifi.com), based in Pompano Beach, Florida, is a leading technology provider that focuses on the life insurance and financial services markets. Aplifi offers solutions that facilitate more compliant and “in good order” insurance transactions, driving increased business. Aplifi’s products include AFFIRM for Annuities, AFFIRM for Life, InsureSocket, I-Relay and PolicyBox. We Simplify Selling Insurance!



The Aplifi logo is available at http://ping.fm/Bk99v


CONTACT: Roy Goodart
Senior Vice President Marketing
Aplifi
800.861.8908 ext. 706
roy.goodart@aplifi.com



News

http://bit.ly/p59cth

Hill International Selected as Construction Manager for Expansion of Morine-Merdare Motorway in Kosovo

Listen to this Post. Powered by iSpeech.org



MARLTON, N.J. and PRISTINA, Kosovo, Aug. 15, 2011 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL), the global leader in managing construction risk, announced today that it has been awarded a contract by the Ministry of Infrastructure of the Republic of Kosovo to provide construction supervision and management services for the rehabilitation and expansion of the Morin�-Merdare Motorway (Route 7). The three-year contract has an estimated value to Hill of approximately €6.95 million (.9 million).



The Morin�-Merdare Motorway is of strategic importance to Kosovo’s economy and constitutes one of two main links to the regional transport network and neighboring capital cities. �It also acts as a primary artery running through Pristina, the capital of the Republic of Kosovo, and connecting it with many of the country’s main cities and economic centers.



The expanded Morin�-Merdare Motorway will have a total length of approximately 117 kilometers and will include the construction of four tunnels whose total length is estimated at 5 kilometers.�The rehabilitation and expansion of the Morin�-Merdare Motorway is the largest infrastructure project ever undertaken by the Kosovo government.



“We look forward to helping the Ministry successfully complete this important infrastructure project,” said Raouf S. Ghali, President of Hill’s Project Management Group (International).



Hill International, with 3,100 employees in 100 offices worldwide, provides program management, project management, construction management and construction claims and consulting services.�Engineering News-Record magazine recently ranked Hill as the 8th largest construction management firm in the United States.�For more information on Hill, please visit our website at www.hillintl.com.



The Hill International, Inc. logo is available at http://ping.fm/ZaLdr



Certain statements contained in this press release may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is our intent that any such statements be protected by the safe harbor created thereby. �Except for historical information contained in this press release, the matters set forth herein including, but not limited to, any projections of earnings or other financial items; any statements concerning our plans, strategies and objectives for future operations; and any statements regarding future economic conditions or performance, are forward-looking statements. �These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. �Although we believe that the expectations, estimates and assumptions reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. �Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include: modifications and termination of client contracts; control and operational issues pertaining to business activities that we conduct on our own behalf or pursuant to joint ventures with other parties; difficulties we may incur in implementing our acquisition strategy; the need to retain and recruit key technical and management personnel; and unexpected adjustments and cancellations related to our backlog. �Additional factors that could cause actual results to differ materially from our forward-looking statements are set forth in the reports we have filed with the Securities and Exchange Commission. �We do not intend, and undertake no obligation, to update any forward-looking statement.



(HIL-G)


CONTACT: Hill International, Inc.
John P. Paolin
Vice President of Marketing and Corporate Communications
(856) 810-6210
johnpaolin@hillintl.com

The Equity Group Inc.
Devin Sullivan
Senior Vice President
(212) 836-9608
dsullivan@equityny.com



News

http://bit.ly/otqDI9

Long-Time Health Industry Professional Woodrin Grossman Joins American Specialty Health's Board of Directors

Listen to this Post. Powered by iSpeech.org



SAN DIEGO, Aug. 15, 2011 (GLOBE NEWSWIRE) — Total Population Health Management company American Specialty Health Incorporated (ASH) announced that Woodrin Grossman has joined the company’s Board of Directors. In addition to serving as a director, Grossman will also chair the organization’s Audit and Finance Committee. ASH’s CEO and co-founder George DeVries, Jan DeVries, Christobel Selecky, and Bud Volberding are also ASH board members.



Woodrin Grossman joins ASH after working for PricewaterhouseCoopers for 37 years, including 27 years as a partner of the firm and retiring in 2005 as the chairman of the firm’s national and global health care practice. As chairman, Grossman developed and implemented the firm’s health care practice strategic direction, including service delivery and brand that appealed to Fortune 500, tax-exempt health systems and fast-growing, entrepreneurial health care providers, including health services, insurance, and medical supply companies. The practice grew to include some of the largest and most prominent investor-owned and tax-exempt health systems, academic medical centers, and health insurers.



Grossman’s deep understanding of audit and accounting issues makes him well-suited to serve as ASH’s chairman of the company’s Audit and Finance Committee. He has served as the lead audit partner for audits of Fortune 500 and other companies and dealt with the gamut of audit and accounting issues.



In addition, Grossman has served as director and senior vice president, strategy and development, of Odyssey HealthCare Inc. Currently, Mr.�Grossman also serves on the Board of Directors of Kinetic Concepts, Inc., IPC: The Hospitalist Company, and MedCath Corporation.



“We are very pleased that Mr. Grossman has joined our Board of Directors as both a director and Chair of our Audit and Finance Committee,” said George DeVries, ASH’s chairman, CEO and co-founder. “His deep understanding of finance and the health care industry provides invaluable insight for the ASH Board of Directors.”



For more information on ASH and its leadership team, visit ASHCompanies.com.



About American Specialty Health and Healthyroads



American Specialty Health Incorporated (ASH) is a national health and wellness company that provides prevention and wellness services, specialty network management programs, and fitness and exercise services to health plans, insurance carriers, employer groups, and trust funds. Based in San Diego, ASH has more than 800 employees and serves over 25.9 million members.



Healthyroads, Inc., a total population health management program, offers a wide range of personal health solutions�including award-winning telephone-based lifestyle and condition coaching programs, member engagement promotion programs (EngageHealthyroads.com), incentive management programs, competitive challenges, worksite wellness programs, and/or an integrated online health improvement portal, Healthyroads.com. Healthyroads offers programs to more than 6.1 million members nationally.



For more information about ASH health and wellness programs, visit ASHCompanies.com or call (800) 848-3555. Follow us on Twitter at www.Twitter.com/ASHCompanies or www.Twitter.com/Healthyroads!


CONTACT: Meredith Mulligan
(619) 578-2000
meredithm@ashn.com

Debby Clark
800.848.3555
debbyc@ashn.com



News

http://bit.ly/nMOBsJ

Saturday, August 13, 2011

The Rosen Law Firm Announces Class Action Lawsuit Charging Miller Energy Resources, Inc. With Securities Fraud � MILL

Listen to this Post. Powered by iSpeech.org



NEW YORK, Aug. 13, 2011 (GLOBE NEWSWIRE) — The Rosen Law Firm, P.A. today announced a class action lawsuit has been filed on behalf of investors who purchased the common stock of Miller Energy Resources, Inc. (“Miller” or the “Company”) (NYSE:MILL) during the period from March 15, 2010 through August 1, 2011 (the “Class Period”), seeking to recover investors’ damages from violations of federal securities laws.



To join the Miller class action, visit the Rosen Law Firm’s website at http://www.rosenlegal.com, or call Jonathan Horne, Esq., toll-free, at 866-767-3653; you may also email jhorne@rosenlegal.com for information on the class action. The case is pending in the U.S. District Court for the Eastern District of Tennessee.



NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN AN ABSENT CLASS MEMBER.



The Complaint alleges violations of the Securities Exchange Act against Miller, its Chief Executive Officer, Scott Boruff and CFO Paul Boyd.�The Complaint alleges that the Company overstated the value of assets it purchased in a bankruptcy sale by over 1,000%, and that the Company falsely claimed it had obtained the approval of its registered independent accountant, KPMG, for this valuation.



On July 28, 2011, analysts Melissa Davis and Janice Shell issued a report questioning the valuation.�The report revealed that the assets had been on the market for a year, and that industry experts found the valuation incredible.�On July 29, 2011, Miller issued an annual report on Form 10-K, purporting to rebut the claims, and purporting to include an unqualified audit letter from KPMG.�On August 1, 2011, Miller issued a current report on Form 8-K saying that the July 29 10-K should no longer be relied upon because, among other things, KPMG had not completed its audit.���



Disclosure that its financial statements can no longer be relied on caused Miller’s stock price to drop, damaging investors.



If you wish to serve as lead plaintiff, you must move the Court no later than October 11, 2011. �A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.�If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Jonathan Horne, Esq. of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at jhorne@rosenlegal.com.�You may also visit the firm’s website at http://www.rosenlegal.com.



The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.



Attorney Advertising.�Prior results do not guarantee a similar outcome.


CONTACT: Jonathan Horne, Esq.
The Rosen Law Firm P.A.
275 Madison Avenue, 34th Floor
New York, New York 10016
Tel: (212) 686-1060
Weekends Tel: (917) 797-4425
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
jhorne@rosenlegal.com
www.rosenlegal.com



News

http://bit.ly/qHwQbV

Spanish Broadcasting System, Inc. Reports Results for the Second Quarter 2011

Listen to this Post. Powered by iSpeech.org



COCONUT GROVE, Fla., Aug. 12, 2011 (GLOBE NEWSWIRE) — Spanish Broadcasting System, Inc. (the “Company” or “SBS”) (Nasdaq:SBSA) today reported financial results for the three- and six-months ended June 30, 2011.



Please refer to the Non-GAAP Financial Measures and Unaudited Segment Data sections for definitions and a reconciliation of GAAP to non-GAAP financial measures.



Discussion and Results



Raul Alarcón, Jr., Chairman and CEO, commented, “During the second quarter, we continued seeing a gradual improvement in the advertising environment across select markets, including notable strength in our national sales performance. Our station brands remain very strong and continue to deliver leading rating shares across key Hispanic demographics. As we invest in our content and strategically expand our footprint, we are also continuing to carefully manage our operating costs, resulting in improved profitability across our stations.�Looking ahead, we will continue to focus on strengthening our assets, maximizing our performance and capitalizing on the tremendous growth of the Hispanic population.”����



Quarter Results



For the quarter ended June 30, 2011, consolidated net revenue totaled .6 million compared to .8 million for the same prior year period, resulting in a decrease of .2 million or 1%.�Our radio segment net revenue decreased .6 million or 2%, primarily due to local sales, offset by an increase in national and network sales. The decrease in local sales occurred in all of our markets, with the exception of our New York market. The increase in national sales occurred in our New York, Chicago and Puerto Rico markets. �The increase in network sales occurred in all of our markets.�Our television segment net revenue increased .4 million or 10%, primarily due to increases in national spot sales and paid programming sales, offset by a decrease in local spot sales.



Operating income before depreciation and amortization, (gain) loss on the disposal of assets, net, and impairment charges and restructuring costs, a non-GAAP measure, totaled .1 million compared to .8 million for the same prior year period, representing an increase of .3 million or 3%.�This increase was primarily attributed to the decrease in operating expenses and corporate expenses. Please refer to the Non-GAAP Financial Measures and Unaudited Segment Data sections for definitions and a reconciliation of GAAP to non-GAAP financial measures.



Operating income totaled .6 million compared to .3 million for the same prior year period, representing an increase of .3 million or 3%. �This increase was primarily attributed to the decrease in operating expenses and corporate expenses.



Six-Months Ended Results



For the six-months ended June 30, 2011, consolidated net revenue totaled .4 million compared to .7 million for the same prior year period, resulting in a decrease of .3 million or less than 1%. Our radio segment net revenue decreased .2 million or 2%, primarily due to local sales, offset by an increase in national and network sales. The decrease in local sales occurred in all of our markets. The increase in national sales occurred in our New York, Chicago and Puerto Rico markets.�The increase in network sales occurred in all of our markets.�Our television segment net revenue increased .9 million or 12%, primarily due to increases in national spot sales and paid programming sales, offset by a decrease in local spot sales.



Operating income before depreciation and amortization, (gain) loss on the disposal of assets, net, impairment charges and restructuring costs, a non-GAAP measure, totaled .5 million compared to .7 million for the same prior year period, representing a decrease of .2 million or 1%.�This decrease was primarily attributed to the decrease in net revenues, offset by decreases in operating expenses and corporate expenses. Please refer to the Non-GAAP Financial Measures and Unaudited Segment Data sections for definitions and a reconciliation of GAAP to non-GAAP financial measures.



Operating income totaled .7 million for the current and same prior year period, respectively.�



Reverse Stock Split of our Class A and Class B Common Stock



On July 5, 2011, we filed a Certificate of Amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Amendment”). The Amendment effected a one-for-ten (1-for-10) reverse stock split of our outstanding Class A common stock, par value .0001 per share and Class B common stock, par value .0001 per share. The reverse stock split became effective at 11:59p.m., Eastern Standard time on July�11, 2011 (the “Effective Date”).



The reverse stock split was approved by our stockholders at the annual meeting held on June 1, 2011. The trading of our common stock on the NASDAQ Global Market on a split-adjusted basis began at the opening of trading on July 12, 2011, at which time the symbol changed to SBSAD to indicate that the reverse stock split had occurred. The symbol returned to the normal SBSA at the open of the market on August 9, 2011.



As a result of the reverse stock split, each ten (10) outstanding shares of pre-split common stock automatically combined into one (1) share of post-split common stock. No fractional shares were issued. Proportional adjustments were made to our outstanding stock, stock options and other equity awards and to our equity compensation plans to reflect the reverse stock split.�The condensed consolidated Statements of Operations for current and prior periods have been adjusted to reflect the change in number of shares.



NASDAQ Compliance Letter



As a result of the reverse stock split, on July 26, 2011, we received notification from NASDAQ that we had regained compliance with the .00 minimum closing bid price requirement in accordance with NASDAQ listing rules. The NASDAQ Listing Qualifications Panel has determined to continue the listing of our securities on The NASDAQ Stock Market.



About Spanish Broadcasting System, Inc.



Spanish Broadcasting System, Inc. is the largest publicly traded Hispanic-controlled media and entertainment company in the United States.� SBS owns and/or operates 21 radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Tropical, Mexican Regional, Spanish Adult Contemporary and Hurban format genres. SBS operates 3 of the top 6 Spanish-language stations in the nation including the #1 Spanish station in America, WSKQ-FM in New York City. The Company also owns and operates MegaTV, a television operation with over-the-air, cable and satellite distribution and affiliates throughout the U.S. and Puerto Rico. SBS also produces live concerts and events and operates www.LaMusica.com, a bilingual Spanish-English online site providing content related to Latin music, entertainment, news and culture. The Company’s corporate Web site can be accessed at www.spanishbroadcasting.com.



This press release contains certain forward-looking statements.�These forward-looking statements, which are included in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, may involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this press release.�Although the Company believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that actual results will not differ materially from these expectations.�Forward-looking statements, which are based upon certain assumptions and describe future plans, strategies and expectations of the Company, are generally identifiable by use of the words “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” “might,” or “continue” or the negative or other variations thereof or comparable terminology.�Factors that could cause actual results, events and developments to differ are included from time to time in the Company’s public reports filed with the Securities and Exchange Commission.�All forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results, events or developments referenced herein will occur or be realized. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operation results.



�(Financial Table Follows)



Below are the Unaudited Condensed Consolidated Statements of Operations for the three- and six-months ended June 30, 2011 and 2010.



Non-GAAP Financial Measures



Included below are tables that reconcile the three- and six-months ended reported results in accordance with Generally Accepted Accounting Principles (GAAP) to Non-GAAP results.�The tables reconcile Operating Income to Operating Income before Depreciation and Amortization, (Gain) Loss on the Disposal of Assets, net and Impairment Charges and Restructuring Costs.



Operating Income before Depreciation and Amortization, (Gain) Loss on the Disposal of Assets, net, and Impairment Charges and Restructuring Costs are not measures of performance or liquidity determined in accordance with GAAP in the United States.�However, we believe that these measures are useful in evaluating our performance because they reflect a measure of performance for our stations before considering costs and expenses related to our capital structure and dispositions.�These measures are widely used in the broadcast industry to evaluate a company’s operating performance and are used by us for internal budgeting purposes and to evaluate the performance of our stations, segments, management and consolidated operations.�However, these measures should not be considered in isolation or as substitutes for Operating Income, Net Income, Cash Flows from Operating Activities or any other measure used in determining our operating performance or liquidity that is calculated in accordance with GAAP. In addition, because Operating Income before Depreciation and Amortization, (Gain) Loss on the Disposal of Assets, net, Impairment Charges and Restructuring Costs is not calculated in accordance with GAAP, it is not necessarily comparable to similarly titled measures used by other companies.�



Unaudited Segment Data



We have two reportable segments: radio and television.�The following summary table presents separate financial data for each of our operating segments (in thousands):



Selected Unaudited Balance Sheet Information and Other Data:


CONTACT: Analysts and Investors
Joseph A. Garcia
Chief Financial Officer, Chief Administrative Officer,
Senior Executive Vice President and Secretary
(305) 441-6901

Analysts, Investors or Media
Chris Plunkett
Brainerd Communicators, Inc.
(212) 986-6667



News

http://bit.ly/qTsrfV

optionsXpress and Schwab Receive Necessary Regulatory Approvals

Listen to this Post. Powered by iSpeech.org



CHICAGO, Aug. 12, 2011 (GLOBE NEWSWIRE) — optionsXpress Holdings, Inc. (Nasdaq:OXPS) today reported that optionsXpress and The Charles Schwab Corporation (NYSE:SCHW) have obtained all regulatory approvals that are required to complete the previously announced transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”), dated March 18, 2011, by and among optionsXpress, Schwab and Neon Acquisition Corp., a Delaware corporation and wholly-owned direct subsidiary of Schwab. This represents a significant step forward towards completion of the transaction. The transaction is expected to close in the third quarter of 2011 and is subject to customary closing conditions, including approval of stockholders of optionsXpress. The special meeting of stockholders of optionsXpress to vote upon the proposal to approve and adopt the Merger Agreement is scheduled to occur on August 30, 2011.



The optionsXpress Holdings, Inc. logo is available at http://ping.fm/H7bFH



Safe Harbor



This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.� Forward-looking statements include statements that refer to expectations, projections or other characterizations of future events or circumstances and are identified by words such as “believe,” “anticipate,” “expect,” “estimate,” “intend,” “plan,” “will,” “may,” “aim,” “target,” “could,” “should,” “continue,” “build,” “improve,” “growth,” “increase,” and other similar expressions. These forward-looking statements relate to the business combination transaction involving The Charles Schwab Corporation (“Schwab”) and optionsXpress Holdings, Inc. (“optionsXpress”), including expected synergies; timing of closing; client and stockholder benefits; management; accretion; growth; client retention; and merger-related charges which reflect management’s beliefs, objectives and expectations as of the date hereof.� Achievement of the expressed beliefs, objectives and expectations is subject to risks and uncertainties that could cause actual results to differ materially from those beliefs, objectives or expectations.� Important transaction-related factors that may cause such differences include, but are not limited to, the risk that expected revenue, expense and other synergies from the transaction may not be fully realized or may take longer to realize than expected; the parties are unable to successfully implement their integration strategies; failure of the parties to satisfy the closing conditions in the merger agreement in a timely manner or at all, including the failure of the optionsXpress stockholders to approve the merger; and disruptions to the parties’ businesses as a result of the announcement and pendency of the merger.� Other important factors include general market conditions, including the level of interest rates, equity valuations and trading activity; the parties’ ability to attract and retain clients and grow client assets/relationships; competitive pressures on rates and fees; the level of client assets, including cash balances; the impact of changes in market conditions on money market fund fee waivers, revenues, expenses and pre-tax margins; capital needs; the parties’ ability to develop and launch new products, services and capabilities in a timely and successful manner; the effect of adverse developments in litigation or regulatory matters; any adverse impact of financial reform legislation and related regulations; and other factors set forth in Schwab’s and optionsXpress’ Annual Reports on Form 10-K for the fiscal year ended December 31, 2010.� Schwab and optionsXpress disclaim any obligation and do not intend to update or revise any forward-looking statements.



In connection with the proposed transaction, Schwab filed with the Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 that included a proxy statement/prospectus for the stockholders of optionsXpress.�optionsXpress mailed the final proxy statement/prospectus to its stockholders on or about July 29, 2011.�Investors and security holders are urged to read the proxy statement/prospectus regarding the proposed transaction and other relevant documents filed with the SEC because they contain important information.�Copies of all documents filed with the SEC regarding the proposed transaction may be obtained, free of charge, at the SEC’s website (http://www.sec.gov). These documents, when available, may also be obtained, free of charge, from Schwab’s website, www.aboutschwab.com/investor, under the tab “Financials and SEC Filings” or from optionsXpress’ website, www.optionsXpress.com/investor, under the item “SEC Filings.”



Participants in the Transaction



Schwab, optionsXpress and their respective directors, executive officers and certain other members of management and employees may be deemed to be participants in the solicitation of proxies from the optionsXpress stockholders in respect of the proposed transaction.�Information regarding the persons who may, under the rules of the SEC, be deemed to be participants in the solicitation of the stockholders of optionsXpress in connection with the proposed transaction are set forth in the proxy statement/prospectus as filed with the SEC on July 27, 2011.�Information about Schwab’s executive officers and directors is available in Schwab’s Annual Report on Form 10-K filed with the SEC on February 25, 2011 and Schwab’s definitive proxy statement filed with the SEC on March 30, 2011, as amended on May 9, 2011.�Information about optionsXpress’ executive officers and directors is available in optionsXpress’ Amendment No. 1 to the Annual Report on Form 10-K filed with the SEC on April 27, 2011.�You can obtain free copies of these documents from Schwab and optionsXpress using the contact information above.


CONTACT: optionsXpress Investor Hotline
(877) 280-9010



News

http://bit.ly/riy98F

Enterprise Bank & Trust Assumes All Deposits and Acquires Certain Assets of the First National Bank of Olathe

Listen to this Post. Powered by iSpeech.org



ST. LOUIS, Aug. 12, 2011 (GLOBE NEWSWIRE) — Enterprise Bank & Trust, a subsidiary of Enterprise Financial Services Corp (Nasdaq:EFSC), announced that it has entered into a purchase and assumption agreement with the Federal Deposit Insurance Corporation (FDIC) to assume all of the deposits and acquire certain assets, including trust accounts, of The First National Bank of Olathe (FNB) in Johnson County KS. As part of the transaction, Enterprise and the FDIC have entered into a loss sharing agreement whereby the FDIC will reimburse Enterprise for certain losses incurred on the assets acquired.



At June 30, 2011, FNB reported assets of approximately 8 million, loans of approximately 6 million, other real estate owned of approximately 0 million and deposits of approximately 4 million.���



FNB’s branches will open on Saturday, August 13, 2011 as branches of Enterprise Bank & Trust.�FNB’s depositors will automatically become depositors of Enterprise Bank & Trust and their deposits will continue to be insured by the FDIC to the maximum permitted by law. �FNB’s trust clients will also become clients of Enterprise Bank & Trust.



Depositors of FNB can access their money by writing checks or using ATM or debit cards. Checks drawn on FNB will continue to be processed and loan customers should continue to make their payments as usual.�Customers can continue to bank as they normally do.



“We are delighted to welcome The First National Bank’s clients to Enterprise Bank & Trust,” said Peter Benoist, President and CEO for Enterprise. “They can be assured that their deposits are safe and readily accessible.�We’re proud to become part of the heritage of First National and look forward to building on its tradition of service to the Olathe community.”



�”This acquisition dramatically strengthens our presence in Kansas City,” noted Benoist.�”It’s our third acquisition in this market over the past four years, increasing our Kansas City deposits to more than billion.�These acquisitions demonstrate our commitment to the market and our enthusiasm for the growth potential it represents for Enterprise.”�



The FNB transaction is expected to be immediately accretive to net income, diluted earnings per share and book value per common share.�It was the Company’s fourth FDIC-assisted transaction since December 2009.�



Enterprise operates seven branches in the Kansas City area in addition to the six FNB branches that it has acquired.�Linda Hanson is Regional President and Sam Pepper is Chief Operating Officer for the Kansas City region.



Enterprise Financial Services Corp operates commercial banking and wealth management businesses in metropolitan St. Louis, Kansas City and Phoenix.�The Company is primarily focused on serving the needs of privately held businesses, their owner families, executives and professionals.�



Readers should note that in addition to the historical information contained herein, this press release contains forward-looking statements, which are inherently subject to risks and uncertainties that could cause actual results to differ materially from those contemplated from such statements.�We use the words “expect” and “intend” and variations of such words and similar expressions in this communication to identify such forward-looking statements.�Factors that could cause or contribute to such differences include, but are not limited to, burdens imposed by federal and state regulations of banks, credit risk, exposure to local and national economic conditions, risks associated with rapid increase or decrease in prevailing interest rates, effects of mergers and acquisitions, effects of critical accounting policies and judgments, legal and regulatory developments and competition from banks and other financial institutions, as well as other risk factors described in the Company’s 2010 Annual Report on Form 10-K.�Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update them in light of new information or future events unless required under the federal securities laws.


CONTACT: Jerry Mueller, Senior Vice President
(314) 497-7770
Justin LaBerge, APR, Sturges Word Communications
(785) 766-5688



News

http://bit.ly/ocWfph

Friday, August 12, 2011

Investors Capital Holdings Q1 Revenue Increases 2.4%

Listen to this Post. Powered by iSpeech.org



LYNNFIELD, Mass., Aug. 12, 2011 (GLOBE NEWSWIRE) — Investors Capital Holdings, Ltd. (NYSE Amex:ICH) (the “Company”), a financial services holding company, posted first quarter revenue of .44 million for the period ended June 30, 2011 (the “quarter”). This represents a 2.4% increase over revenue of .94 million for the quarter ended June 30, 2010 (“prior period”). Investors Capital Holdings, Ltd. operates primarily through its wholly-owned subsidiary, Investors Capital Corporation (“ICC”), a dually registered broker-dealer and investment advisory firm.



Total revenue increased primarily due to a rise in advisory fees. Commission revenue, which accounts for 78.9% of total revenue, increased 1.4% to .92 million. Advisory fees, which make up 19.5% of total revenue, grew 12.1% to .18 million. The rise in advisory fee revenue reflects increases in the value of underlying advisory program assets augmented by new investment contributions.



Investors Capital continues to benefit from enhancing the overall quality of its representatives by helping them expand their skills and practices, recruiting established, high-quality representatives, and terminating lower-quality advisors. The firm’s average revenue per representative, based on a rolling 12-month period, rose at quarter-end to 0,943, an increase of 15.3% over 9,587 for the prior rolling 12-month period.



Operations were largely impacted by litigation and regulatory actions accompanying a more demanding industry regulatory environment. Total expenses rose 6.1%, led by regulatory, legal, and professional services expenses, which increased 58.5%. Non-recurring professional and legal expenses related to the firm’s secondary offering also contributed to the rise in total expenses for the current period. The result was a net loss of .26 million for the quarter compared to a net loss of .01 million for the prior period.



Quarterly adjusted EBITDA was negative .35 million as opposed to .12 million for the prior period. Adjusted EBITDA, a non-GAAP financial measure described below, is a key metric utilized by the firm in evaluating its financial performance.



“While we realized revenue growth, the effects of the recession, regulatory assessments, and non-recurring expenses continue to impact our bottom line and slow the pace of our growth,” said Timothy B. Murphy, President and CEO of Investors Capital Holdings, Ltd. “However, our net capital is strong, and our recruiting pipeline is substantial. I firmly believe that by reducing our non-recurring expenses, paired with increased revenues, we can look forward to a return to profitability.”



About Investors Capital Holdings, Ltd.:



Investors Capital Holdings, Ltd. (NYSE Amex:ICH) of Lynnfield, Massachusetts is a financial services holding company that operates primarily through its broker/dealer and investment advisor subsidiary, Investors Capital Corporation. Our mission is to provide 5-star service and support to our valued registered representatives, including advisory programs, strategic practice management and marketing services, and technology, to help them grow their businesses and exceed their clients’ expectations. Business units include Investors Capital Corporation, ICC Insurance Agency, Inc., and Investors Capital Holdings Securities Corporation. For more information, please call (800) 949-1422 x4814 or visit www.investorscapital.com.



Certain statements contained in this press release that are not historical fact may be deemed to be forward-looking statements under federal securities laws. There are many factors that could cause our future actual results to differ materially from those suggested by or forecast in the forward-looking statements. Such factors include, but are not limited to, general economic conditions, interest rate fluctuations, regulatory changes affecting the financial services industry, competitive factors effecting demand for our services, availability of funding, and other risks including those identified in the Company’s Securities and Exchange Commission filings.



Investors Capital Holdings, Ltd., 230 Broadway, Lynnfield, Massachusetts 01940, Distributor.



Adjusted EBITDA



Adjusted EBITDA is defined as earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted by eliminating items that we believe are not part of our core operations, are non-recurring items of revenue or expense, or do not involve a cash outlay, such as stock-related compensation.�We consider adjusted EBITDA important in monitoring and evaluating our financial performance on a consistent basis across various periods. We also use adjusted EBITDA as a primary measure, among others, to analyze and evaluate financial and strategic planning decisions.



Adjusted EBITDA is considered a non-GAAP financial measure as defined by Regulation�G promulgated by the SEC under the Securities Act of 1933, as amended.�Adjusted EBITDA should be considered in addition to, rather than as a substitute for, important GAAP financial measures including pre-tax income, net income and cash flows from operating activities.�Items excluded from adjusted EBITDA are significant and necessary components to the operations of our business; therefore, adjusted EBITDA should only be used as a supplemental measure of our operating performance.



Adjusted EBITDA may be reconciled with net income as follows:


CONTACT: Robert Foney, Chief Marketing Officer
781.477.4814
rfoney@investorscapital.com
www.investorscapital.com



News

http://bit.ly/pHzMfN